(PharmaNewsWire.Com, April 23, 2019 ) The Research Report on HPV Testing and Pap Test Market provides a detailed overview of major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.
Several factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.
An increasing number of cervical cancer cases and a growing aging population
Cervical cancer is the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012. This figure is expected to reach to 609,270 new cases and 315,727 deaths by 2020.
HPV Testing & Pap Test Market Based on Application;
Based on the application, the Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is expected to grow at the highest CAGR during the forecast period, owing to the growing incidences of cervical cancer.
Global HPV testing and Pap test Market, by Region
- North America - Europe - Asia Pacific - Rest of the World (RoW)
HPV Testing & Pap Test Market Based on end user;
On the basis of end user, the HPV testing and Pap test market is categorized into hospitals, laboratories, physician’s offices and clinics. The hospitals segment is projected to grow at the highest CAGR. This growth is attributed to the increasing patient volumes in hospitals, as most diagnostic tests are carried out in-house with advanced technologies and more accessibility.
HPV Testing & Pap Test Market’s Major Key Players:
Key players in the HPV testing and Pap test market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
